Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Larsson, E. Mirgorodskaya, L. Andersson, A. Bredberg, A. C. Almstrand, E. Ljungström, A. C. Olin (Gothenburg, Sweden). Analysis of SpA in exhaled particles. Eur Respir J 2010; 36: Suppl. 54, 5357

Member's Comments

No comment yet.

Related content which might interest you: Proteomic analysis of exhaled endogenous particles non-invasively sampled from the airways Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Clinical evaluation of exhaled nitric oxide measurement in monitoring childhood asthma Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010 Analysis of exhaled breath condensate cytokine pattern in lung transplant recipients with and without BOS Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010 Relationship between exhaled nitric oxide and exacerbation frequency in COPD patients: A longitudinal study Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007 Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 237s Year: 2004 Exhaled air analysis Source: International Congress 2016 – New tools for the early diagnosis of acute respiratory distress syndrome Year: 2016 Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Biomarkers in asthma and COPD Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 Protein pattern of exhaled breath condensate (EBC) and saliva Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001 Methodology of exhaled breath condensate Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide Year: 2009 Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases Year: 2010 Correlation of LTB4 with α-amylase in exhaled breath condensate Source: Eur Respir J 2005; 26: Suppl. 49, 372s Year: 2005 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Determinants of variability in exhaled breath condensate (EBC) in children Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 External validation of exhaled breath molecular profiling in identifying COPD and asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Increased exhaled nitric oxide predicts new-onset rhinitis in asymptomatic children Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011